• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲基lycaconitine类似物对人α7烟碱型乙酰胆碱受体的合成及拮抗活性

Synthesis and Antagonist Activity of Methyllycaconitine Analogues on Human α7 Nicotinic Acetylcholine Receptors.

作者信息

Qasem Ashraf M A, Rowan Michael G, Sanders Victoria R, Millar Neil S, Blagbrough Ian S

机构信息

School of Pharmacy, University of Bath, Bath BA2 7AY, U.K.

Department of Neuroscience, Physiology and Pharmacology, University College London, Gower Street, London WC1E 6BT, U.K.

出版信息

ACS Bio Med Chem Au. 2023 Feb 14;3(2):147-157. doi: 10.1021/acsbiomedchemau.2c00057. eCollection 2023 Apr 19.

DOI:10.1021/acsbiomedchemau.2c00057
PMID:37096031
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10119942/
Abstract

Methyllycaconitine (MLA), , is a naturally occurring norditerpenoid alkaloid that is a highly potent (IC = 2 nM) selective antagonist of α7 nicotinic acetylcholine receptors (nAChRs). Several structural factors affect its activity such as the neopentyl ester side-chain and the piperidine ring N-side-chain. The synthesis of simplified AE-bicyclic analogues - possessing different ester and nitrogen side-chains was achieved in three steps. The antagonist effects of synthetic analogues were examined on human α7 nAChRs and compared to that of MLA . The most efficacious analogue () reduced α7 nAChR agonist responses [1 nM acetylcholine (ACh)] to 53.2 ± 1.9% compared to 3.4 ± 0.2% for MLA . This demonstrates that simpler analogues of MLA possess antagonist effects on human α7 nAChRs but also indicates that further optimization may be possible to achieve antagonist activity comparable to that of MLA .

摘要

甲基lycaconitine(MLA)是一种天然存在的去甲二萜生物碱,是α7烟碱型乙酰胆碱受体(nAChRs)的高效(IC = 2 nM)选择性拮抗剂。几个结构因素会影响其活性,如新戊酯侧链和哌啶环N侧链。通过三步反应实现了具有不同酯和氮侧链的简化AE双环类似物的合成。研究了合成类似物对人α7 nAChRs的拮抗作用,并与MLA进行了比较。最有效的类似物将α7 nAChR激动剂反应[1 nM乙酰胆碱(ACh)]降低至53.2±1.9%,而MLA为3.4±0.2%。这表明MLA的更简单类似物对人α7 nAChRs具有拮抗作用,但也表明可能需要进一步优化以实现与MLA相当的拮抗活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/cdd13d0fb9fa/bg2c00057_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/83ab57bf2c7c/bg2c00057_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/e50e89733faf/bg2c00057_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/3ac48098111a/bg2c00057_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/40518d2b5478/bg2c00057_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/036f696bf717/bg2c00057_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/b9fedf04fb4d/bg2c00057_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/68ac924c35b1/bg2c00057_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/3b1f185f48f6/bg2c00057_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/034ce0f8f6b7/bg2c00057_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/cdd13d0fb9fa/bg2c00057_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/83ab57bf2c7c/bg2c00057_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/e50e89733faf/bg2c00057_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/3ac48098111a/bg2c00057_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/40518d2b5478/bg2c00057_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/036f696bf717/bg2c00057_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/b9fedf04fb4d/bg2c00057_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/68ac924c35b1/bg2c00057_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/3b1f185f48f6/bg2c00057_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/034ce0f8f6b7/bg2c00057_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1a3/10125343/cdd13d0fb9fa/bg2c00057_0007.jpg

相似文献

1
Synthesis and Antagonist Activity of Methyllycaconitine Analogues on Human α7 Nicotinic Acetylcholine Receptors.甲基lycaconitine类似物对人α7烟碱型乙酰胆碱受体的合成及拮抗活性
ACS Bio Med Chem Au. 2023 Feb 14;3(2):147-157. doi: 10.1021/acsbiomedchemau.2c00057. eCollection 2023 Apr 19.
2
AE Succinimide, an Analogue of Methyllycaconitine, When Bound Generates a Nonconducting Conformation of the α4β2 Nicotinic Acetylcholine Receptor.AE 琥珀酰亚胺,马钱子乙素类似物,与 α4β2 型烟碱型乙酰胆碱受体结合后产生非传导构象。
ACS Chem Neurosci. 2020 Feb 5;11(3):344-355. doi: 10.1021/acschemneuro.9b00525. Epub 2020 Jan 14.
3
Methyllycaconitine analogues have mixed antagonist effects at nicotinic acetylcholine receptors.甲基lycaconitine类似物对烟碱型乙酰胆碱受体具有混合拮抗作用。
Bioorg Med Chem. 2005 Jul 15;13(14):4565-75. doi: 10.1016/j.bmc.2005.04.054.
4
Identifying the binding site of novel methyllycaconitine (MLA) analogs at α4β2 nicotinic acetylcholine receptors.鉴定新型甲基麻古碱(MLA)类似物在α4β2 烟碱型乙酰胆碱受体上的结合位点。
ACS Chem Neurosci. 2010 Dec 15;1(12):796-809. doi: 10.1021/cn100073x. Epub 2010 Oct 7.
5
Novel methyllycaconitine analogues selective for the α4β2 over α7 nicotinic acetylcholine receptors.新型甲基脱氢鹰爪碱类似物,选择性作用于α4β2 型而非α7 型烟碱型乙酰胆碱受体。
Bioorg Med Chem. 2021 Dec 1;51:116516. doi: 10.1016/j.bmc.2021.116516. Epub 2021 Nov 10.
6
α7 nAChRs expressed on antigen presenting cells are insensitive to the conventional antagonists α-bungarotoxin and methyllycaconitine.在抗原呈递细胞上表达的 α7 nAChRs 对传统拮抗剂 α-银环蛇毒素和甲基牛扁碱不敏感。
Int Immunopharmacol. 2020 Apr;81:106276. doi: 10.1016/j.intimp.2020.106276. Epub 2020 Feb 7.
7
Methyllycaconitine: a non-radiolabeled ligand for mapping α7 neuronal nicotinic acetylcholine receptors - in vivo target localization and biodistribution in rat brain.甲基lycaconitine:一种用于绘制α7神经元烟碱型乙酰胆碱受体的非放射性标记配体——大鼠脑内的体内靶点定位和生物分布
J Pharmacol Toxicol Methods. 2012 Jul;66(1):22-8. doi: 10.1016/j.vascn.2012.05.003. Epub 2012 May 16.
8
Synthesis, nicotinic acetylcholine receptor binding, antinociceptive and seizure properties of methyllycaconitine analogs.甲基lycaconitine类似物的合成、烟碱型乙酰胆碱受体结合、抗伤害感受及癫痫特性
Bioorg Med Chem. 2007 Jan 15;15(2):678-85. doi: 10.1016/j.bmc.2006.10.061. Epub 2006 Nov 1.
9
In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.新型选择性 alpha7 型烟碱型乙酰胆碱受体激动剂 ABT-107 的体外药理学特性研究。
J Pharmacol Exp Ther. 2010 Sep 1;334(3):863-74. doi: 10.1124/jpet.110.167072. Epub 2010 May 26.
10
Involvement of the α7-nicotinic acetylcholine receptors in the anti-inflammatory action of the thymulin-related peptide (PAT).α7-烟碱型乙酰胆碱受体参与胸腺肽相关肽(PAT)的抗炎作用。
Neuroscience. 2013 Oct 10;250:455-66. doi: 10.1016/j.neuroscience.2013.07.031. Epub 2013 Jul 21.

引用本文的文献

1
Cholinergic Mechanisms in Gastrointestinal Neoplasia.胆碱能机制在胃肠道肿瘤中的作用。
Int J Mol Sci. 2024 May 13;25(10):5316. doi: 10.3390/ijms25105316.
2
Targeting Alpha7 Nicotinic Acetylcholine Receptors in Lung Cancer: Insights, Challenges, and Therapeutic Strategies.肺癌中α7烟碱型乙酰胆碱受体的靶向作用:见解、挑战与治疗策略
ACS Pharmacol Transl Sci. 2023 Dec 21;7(1):28-41. doi: 10.1021/acsptsci.3c00138. eCollection 2024 Jan 12.

本文引用的文献

1
The 1α-hydroxy-A-rings of norditerpenoid alkaloids are twisted-boat conformers.去甲二萜生物碱的1α-羟基-A环为扭船式构象。
RSC Adv. 2020 May 18;10(32):18797-18805. doi: 10.1039/d0ra03811c. eCollection 2020 May 14.
2
Norditerpenoid alkaloids from and : structural relevance in medicine, toxicology, and metabolism.来自[具体来源未给出]的去甲二萜生物碱:医学、毒理学和代谢中的结构相关性。
Nat Prod Rep. 2022 Mar 23;39(3):460-473. doi: 10.1039/d1np00029b.
3
Homomeric and Heteromeric α7 Nicotinic Acetylcholine Receptors in Health and Some Central Nervous System Diseases.
健康及某些中枢神经系统疾病中的同聚体和异聚体α7烟碱型乙酰胆碱受体
Membranes (Basel). 2021 Aug 29;11(9):664. doi: 10.3390/membranes11090664.
4
Structural diversity, bioactivities, and biosynthesis of natural diterpenoid alkaloids.天然二萜生物碱的结构多样性、生物活性及生物合成
Nat Prod Rep. 2020 Jun 24;37(6):763-796. doi: 10.1039/d0np00002g.
5
The nicotinic acetylcholine receptor: a typical 'allosteric machine'.烟碱型乙酰胆碱受体:一种典型的“变构机器”。
Philos Trans R Soc Lond B Biol Sci. 2018 Jun 19;373(1749). doi: 10.1098/rstb.2017.0174.
6
Allosteric modulation of nicotinic acetylcholine receptors.别构调节烟碱型乙酰胆碱受体。
Biochem Pharmacol. 2015 Oct 15;97(4):408-417. doi: 10.1016/j.bcp.2015.07.028. Epub 2015 Jul 29.
7
A series of α7 nicotinic acetylcholine receptor allosteric modulators with close chemical similarity but diverse pharmacological properties.一系列具有紧密化学相似性但具有不同药理学性质的α7 烟碱型乙酰胆碱受体变构调节剂。
Mol Pharmacol. 2012 May;81(5):710-8. doi: 10.1124/mol.111.076026. Epub 2012 Feb 10.
8
Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.通过变构跨膜位点增强α7烟碱型乙酰胆碱受体功能。
Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14686-91. doi: 10.1073/pnas.0804372105. Epub 2008 Sep 12.
9
Diversity of vertebrate nicotinic acetylcholine receptors.脊椎动物烟碱型乙酰胆碱受体的多样性
Neuropharmacology. 2009 Jan;56(1):237-46. doi: 10.1016/j.neuropharm.2008.07.041. Epub 2008 Aug 5.
10
The synthesis of 5-substituted ring E analogs of methyllycaconitine via the Suzuki-Miyaura cross-coupling reaction.通过铃木-宫浦交叉偶联反应合成甲基lycaconitine的5-取代环E类似物。
Bioorg Med Chem. 2008 Apr 1;16(7):3816-24. doi: 10.1016/j.bmc.2008.01.050. Epub 2008 Jan 31.